Hamartoma Syndrome, Multiple
|
0.010 |
Biomarker
|
disease |
BEFREE |
We conclude that the CSB-PGBD3 fusion protein substantially reshapes the transcriptome in CS patient CS1AN and that continued expression of the CSB-PGBD3 fusion protein in the absence of functional CSB may affect the clinical presentation of CS patients by directly altering the transcriptional program.
|
23028371 |
2012 |
Xeroderma Pigmentosum, Complementation Group D
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in some other DNA repair genes, including XPD (ERCC2), XRCC1 and ERCC6 (CSB) have also been reported to be associated with AMD.
|
23202958 |
2012 |
Cortical cataract
|
0.010 |
Biomarker
|
disease |
BEFREE |
We conclude that the CSB-PGBD3 fusion protein substantially reshapes the transcriptome in CS patient CS1AN and that continued expression of the CSB-PGBD3 fusion protein in the absence of functional CSB may affect the clinical presentation of CS patients by directly altering the transcriptional program.
|
23028371 |
2012 |
Skin carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These hypothesis-generating findings suggest that functional variants in ERCC6 may be associated with an increased risk of NMSC that may be specific to BCC.
|
22336945 |
2012 |
Experimental Organism Basal Cell Carcinoma
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
These hypothesis-generating findings suggest that functional variants in ERCC6 may be associated with an increased risk of NMSC that may be specific to BCC.
|
22336945 |
2012 |
Carcinoma, Basal Cell
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These hypothesis-generating findings suggest that functional variants in ERCC6 may be associated with an increased risk of NMSC that may be specific to BCC.
|
22336945 |
2012 |
Huntington Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
To test the role of CSB in vivo, we measured intergenerational and somatic expansion of CAG tracts in HD mice lacking CSB, OGG1, or both.
|
21566259 |
2011 |
Herpes Simplex Infections
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The effects of UV irradiation on herpes simplex virus type 1 (HSV-1) gene expression and DNA replication were examined in cell lines containing mutations inactivating the XPA gene product required for nucleotide-excision repair, the DNA polymerase eta responsible for translesion synthesis, or the Cockayne syndrome A and B (CSA and CSB) gene products required for transcription-coupled nucleotide excision repair.
|
20215648 |
2010 |
Malignant neoplasm of larynx
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Pro-carriers of ERCC6 Arg1230Pro showed a decreased risk for laryngeal cancer (OR = 0.53, 95% CI 0.34-0.85), strongest in heavy smokers and high alcohol consumers.
|
19444904 |
2009 |
Carcinoma of larynx
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Pro-carriers of ERCC6 Arg1230Pro showed a decreased risk for laryngeal cancer (OR = 0.53, 95% CI 0.34-0.85), strongest in heavy smokers and high alcohol consumers.
|
19444904 |
2009 |
Mouth Neoplasms
|
0.010 |
GeneticVariation
|
group |
LHGDN |
A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients.
|
17933579 |
2008 |
Malignant neoplasm of mouth
|
0.010 |
Biomarker
|
group |
BEFREE |
As for ERCC6 codon 1097 or 1413, there was no difference in distribution between the oral cancer and control groups.
|
17933579 |
2008 |
Lip and Oral Cavity Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
As for ERCC6 codon 1097 or 1413, there was no difference in distribution between the oral cancer and control groups.
|
17933579 |
2008 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
However, the Cockayne syndrome caused by the ERCC6 defect has not been linked to cancer predisposition; likely due to the fact that cells with severe disruption of the ERCC6 function are sensitive to lesion-induced apoptosis, thus reducing the chance of tumorigenesis.
|
17854076 |
2008 |
Trichohepatoenteric Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To refine the delineation of the syndrome on genetically proven COFS cases.
|
18628313 |
2008 |
Glycogen storage disease type II
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
ERCC6 C-6530>G was associated with AMD susceptibility, both independently and through interaction with an SNP (rs380390) in the complement factor H (CFH) intron reported to be highly associated with AMD.
|
16754848 |
2006 |
Trichothiodystrophy Syndromes
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Subtle differences in the effects of these different mutations on the many activities of TFIIH and on its stability determine the clinical outcomes, which can be XP, TTD, XP with CS, XP with TTD or COFS.
|
14726016 |
2003 |
Malnutrition
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The gene expression and deficiency phenotypes of Cockayne syndrome B protein in Caenorhabditis elegans.
|
12095617 |
2002 |
Squamous cell carcinoma of the head and neck
|
0.010 |
Biomarker
|
disease |
BEFREE |
Reduced expression of ERCC1, XPB/ERCC3, XPG/ERCC5, and CSB/ERCC6 is associated with a more than two-fold increased risk of SCCHN.
|
11900225 |
2002 |
Malignant neoplasm of skin
|
0.010 |
Biomarker
|
disease |
BEFREE |
In contrast to the human syndrome, CSB-deficient mice show increased susceptibility to skin cancer.
|
9150142 |
1997 |
nervous system disorder
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutations in the CSA and CSB genes are causative of Cockayne syndrome neurological disorder.
|
31546172 |
2019 |
MYELODYSPLASTIC SYNDROME
|
0.020 |
GeneticVariation
|
group |
BEFREE |
In the screening cohort, 6 candidate SNPs were associated with the tendency to develop MDS: rs4135113 (TDG, p = 0.03), rs12917 (MGMT, p = 0.003), rs2230641 (CCNH, p = 0.01), rs2228529 and rs2228526 (ERCC6, p = 0.04 and p = 0.03), and rs1799977 (MLH1, p = 0.04).
|
30861523 |
2019 |
MYELODYSPLASTIC SYNDROME
|
0.020 |
Biomarker
|
group |
BEFREE |
We evaluated a possible role of DNA repair pathways using gene expression of single-strand break (XPA, XPC, XPG/ERCC5, CSA/ERCC8, and CSB/ERCC6) and double-strand break (ATM, BRCA1, BRCA2, RAD51, XRCC5, XRCC6, LIG4) in 92 patients with myelodysplastic syndrome (73 de novo, 9 therapy-related (t-MDS).
|
31667665 |
2019 |
Gastritis, Atrophic
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Our results demonstrated pairwise epistatic interactions between ERCC6 and ERCC8 SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric cancer.
|
28562347 |
2017 |
Malignant neoplasm of colon and/or rectum
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer.
|
28665687 |
2017 |